Colleen Laughery, LAC Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1140 Route 72 W, Manahawkin, NJ 08050 Phone: 609-978-8972 |
Mr. Paul Michael Santasieri, LPC Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 177 Neptune Dr, Manahawkin, NJ 08050 Phone: 609-713-5662 |
Kathrine Evans, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 216 Neptune Dr, Manahawkin, NJ 08050 Phone: 609-618-4425 |
News Archive
Back when rate shock, website problems and lagging enrollment were threatening to unravel the new health care law before it fully took effect, I concluded a column on Obamacare's repeated near-death experiences with the following warning to conservatives: ... What isn't killed outright grows stronger the longer it's embedded in the federal apparatus, gaining constituents and interest-group support just by virtue of its existence even if it doesn't work out the way it was designed. ... the serious right-of-center alternatives to Obamacare have always included policies to expand coverage, and with a coverage expansion accomplished, Republicans may find themselves effectively forced in a more serious direction. ... wherever they go and whatever they do, they will have to deal with the reality that Obamacare, thrice-buried, looks very much alive (Ross Douthat, 3/31).
Over a year after the outbreak of Salmonella in peanut butter that sickened hundreds and caused the deaths of at least nine, criminal prosecution of the responsible parties has yet to begin.
Immune response measured in tumor biopsies during the course of early treatment predicts which melanoma patients will benefit from specific immune checkpoint blockade drugs, researchers at The University of Texas MD Anderson Cancer Center report in the journal Cancer Discovery.
Watson Pharmaceuticals, Inc. today reported net revenue grew 29 percent for the second quarter ended June 30, 2010 to $875.3 million, compared to $677.8 million in the second quarter 2009. On an adjusted cash basis, net income increased 22 percent to $102.8 million or $0.83 per share, compared to $84.2 million or $0.73 per share in the second quarter 2009. GAAP earnings for the second quarter 2010 were $0.57 per share, compared to $0.46 per share in the prior year period.
› Verified 7 days ago